Stanley Charles Erck's Insider Trades & SAST Disclosures

Stanley Charles Erck's most recent trade in MaxCyte Inc was a trade of 50,790 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 18, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
MaxCyte Inc
Stanley Charles Erck Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 50,790 50,790 - - Stock Option (right to buy)
MaxCyte Inc
Stanley Charles Erck Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jun 2025 29,210 298,328 - 0 Common Stock
MaxCyte Inc
Stanley Charles Erck Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 01 Nov 2024 47,689 316,807 - 0.0 1,908 Common Stock
MaxCyte Inc
Stanley Charles Erck Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Nov 2024 47,689 0 - - Employee Stock Option (right to buy)
MaxCyte Inc
Stanley Charles Erck Director Sale of securities on an exchange or to another person at price $ 3.72 per share. 01 Nov 2024 47,689 269,118 - 3.7 177,403 Common Stock
MaxCyte Inc
Stanley Charles Erck Non-Executive Director 01 Nov 2024 47,689 247,751 (0%) 0% 3.7 177,198 Ords 0.01p
MaxCyte Inc
Stanley Charles Erck Non-Executive Director 01 Nov 2024 47,689 295,440 (0%) 0% 0.0 1,908 Ords 0.01p
MaxCyte Inc
Stanley Charles Erck Non-Executive Director 02 Oct 2024 21,607 247,751 (0%) 0% 0 Ords
MaxCyte Inc
Stanley Charles Erck Non-Executive Director 02 Oct 2024 21,607 269,358 (0%) 0% 0.0 864 Ords
MaxCyte Inc
Stanley Charles Erck Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2024 26,082 69,296 - - Employee Stock Option (right to buy)
MaxCyte Inc
Stanley Charles Erck Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 01 Oct 2024 26,082 295,200 - 0.0 1,043 Common Stock
MaxCyte Inc
Stanley Charles Erck Director Sale of securities on an exchange or to another person at price $ 3.78 per share. 01 Oct 2024 26,082 269,118 - 3.8 98,590 Common Stock
MaxCyte Inc
Stanley Charles Erck Non-Executive Director 01 Oct 2024 26,082 247,751 (0%) 0% 0 Ords
MaxCyte Inc
Stanley Charles Erck Non-Executive Director 01 Oct 2024 26,082 273,833 (0%) 0% 0.0 1,043 Ords
MaxCyte Inc
Stanley Charles Erck Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2024 21,607 47,689 - - Employee Stock Option (right to buy)
MaxCyte Inc
Stanley Charles Erck Director Sale of securities on an exchange or to another person at price $ 3.71 per share. 01 Oct 2024 21,607 269,118 - 3.7 80,162 Common Stock
MaxCyte Inc
Stanley Charles Erck Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 01 Oct 2024 21,607 290,725 - 0.0 864 Common Stock
MaxCyte Inc
Stanley Charles Erck Non-Executive Director Sale of securities on an exchange or to another person at price $ 3.97 per share. 04 Sep 2024 29,767 247,751 (0%) 0% 4.0 118,133 Ords 0.01p
MaxCyte Inc
Stanley Charles Erck Non-Executive Director 04 Sep 2024 29,767 277,518 (0%) 0% 0.0 1,191 Ords 0.01p
MaxCyte Inc
Stanley Charles Erck Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Sep 2024 29,767 95,378 - - Employee Stock Option (right to buy)
MaxCyte Inc
Stanley Charles Erck Director Sale of securities on an exchange or to another person at price $ 3.97 per share. 03 Sep 2024 29,767 269,118 - 4.0 118,175 Common Stock
MaxCyte Inc
Stanley Charles Erck Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 03 Sep 2024 29,767 298,885 - 0.0 1,191 Common Stock
MaxCyte Inc
Stanley Charles Erck Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. 03 Sep 2024 17,922 287,040 - 0.0 717 Common Stock
MaxCyte Inc
Stanley Charles Erck Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 03 Sep 2024 17,922 125,145 - - Employee Stock Option (right to buy)
MaxCyte Inc
Stanley Charles Erck Director Sale of securities on an exchange or to another person at price $ 4.10 per share. 03 Sep 2024 17,922 269,118 - 4.1 73,480 Common Stock
MaxCyte Inc
Stanley Charles Erck Non-Executive Director Sale of securities on an exchange or to another person at price $ 4.10 per share. 03 Sep 2024 17,922 247,751 (0%) 0% 4.1 73,441 Ords 0.01p
MaxCyte Inc
Stanley Charles Erck Non-Executive Director 03 Sep 2024 17,922 265,673 (0%) 0% 0.0 717 Ords 0.01p
MaxCyte Inc
Stanley Charles Erck Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 40,701 40,701 - - Stock Option (right to buy)
MaxCyte Inc
Stanley Charles Erck Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Jun 2024 21,367 269,118 - 0 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Sep 2022 6,546 0 - - Restricted Stock Units
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Sep 2022 6,546 34,026 (0%) 0% - Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.87 per share. 26 Sep 2022 2,180 31,846 (0%) 0% 18.9 41,137 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 62,211 62,211 - - Stock Option (Right to Buy)
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Mar 2022 41,474 41,474 - - Restricted Stock Units
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2021 6,967 13,933 - - Restricted Stock Units
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 14 Dec 2021 6,967 30,846 (0%) 0% - Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 168.43 per share. 14 Dec 2021 3,366 27,480 (0%) 0% 168.4 566,935 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Oct 2021 32,000 36,499 - - Stock Option (Right to Buy)
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.60 per share. 04 Oct 2021 32,000 55,879 (0%) 0% 27.6 883,200 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.00 per share. 04 Oct 2021 10,829 66,708 (0%) 0% 27 292,383 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 04 Oct 2021 10,829 0 - - Stock Option (Right to Buy)
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 177.58 per share. 04 Oct 2021 8,890 36,242 (0%) 0% 177.6 1,578,724 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 178.46 per share. 04 Oct 2021 8,563 27,679 (0%) 0% 178.5 1,528,182 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 173.45 per share. 04 Oct 2021 5,038 56,532 (0%) 0% 173.4 873,829 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 176.48 per share. 04 Oct 2021 4,700 45,132 (0%) 0% 176.5 829,434 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 172.36 per share. 04 Oct 2021 3,746 61,570 (0%) 0% 172.4 645,672 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 175.61 per share. 04 Oct 2021 3,600 49,832 (0%) 0% 175.6 632,198 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 179.48 per share. 04 Oct 2021 3,300 24,379 (0%) 0% 179.5 592,282 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 174.56 per share. 04 Oct 2021 3,100 53,432 (0%) 0% 174.6 541,142 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 166.98 per share. 04 Oct 2021 1,392 65,316 (0%) 0% 167.0 232,441 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 180.58 per share. 04 Oct 2021 500 23,879 (0%) 0% 180.6 90,290 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2021 35,000 10,829 - - Stock Option (Right to Buy)
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.00 per share. 01 Oct 2021 35,000 72,879 (0%) 0% 27 945,000 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Oct 2021 14,000 68,499 - - Stock Option (Right to Buy)
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.60 per share. 01 Oct 2021 14,000 37,879 (0%) 0% 27.6 386,400 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 177.37 per share. 01 Oct 2021 6,227 36,521 (0%) 0% 177.4 1,104,474 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 174.30 per share. 01 Oct 2021 5,853 48,951 (0%) 0% 174.3 1,020,176 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 178.27 per share. 01 Oct 2021 4,604 31,917 (0%) 0% 178.3 820,753 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 172.02 per share. 01 Oct 2021 4,103 57,806 (0%) 0% 172.0 705,815 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 175.15 per share. 01 Oct 2021 3,602 45,349 (0%) 0% 175.1 630,878 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 173.16 per share. 01 Oct 2021 3,002 54,804 (0%) 0% 173.2 519,834 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 167.88 per share. 01 Oct 2021 2,801 67,371 (0%) 0% 167.9 470,240 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 171.34 per share. 01 Oct 2021 2,602 61,909 (0%) 0% 171.3 445,814 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 176.24 per share. 01 Oct 2021 2,601 42,748 (0%) 0% 176.2 458,388 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 180.42 per share. 01 Oct 2021 2,541 28,053 (0%) 0% 180.4 458,457 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 169.05 per share. 01 Oct 2021 1,959 65,412 (0%) 0% 169.1 331,175 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 181.21 per share. 01 Oct 2021 1,600 26,453 (0%) 0% 181.2 289,934 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 189.47 per share. 01 Oct 2021 1,502 24,351 (0%) 0% 189.5 284,584 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 179.29 per share. 01 Oct 2021 1,323 30,594 (0%) 0% 179.3 237,200 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 166.62 per share. 01 Oct 2021 1,100 70,172 (0%) 0% 166.6 183,286 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 165.68 per share. 01 Oct 2021 904 71,272 (0%) 0% 165.7 149,777 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 170.07 per share. 01 Oct 2021 901 64,511 (0%) 0% 170.1 153,233 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 164.74 per share. 01 Oct 2021 703 72,176 (0%) 0% 164.7 115,812 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 190.63 per share. 01 Oct 2021 472 23,879 (0%) 0% 190.6 89,978 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 182.40 per share. 01 Oct 2021 300 26,153 (0%) 0% 182.4 54,721 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 183.61 per share. 01 Oct 2021 192 25,961 (0%) 0% 183.6 35,253 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 187.95 per share. 01 Oct 2021 100 25,853 (0%) 0% 188.0 18,795 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 185.75 per share. 01 Oct 2021 8 25,953 (0%) 0% 185.8 1,486 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Sep 2021 6,546 6,546 - - Restricted Stock Units
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 26 Sep 2021 6,546 27,041 (0%) 0% - Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.16 per share. 26 Sep 2021 3,162 23,879 (0%) 0% 248.2 784,682 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2021 27,439 0 - - Stock Option (Right to Buy)
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 121.00 per share. 01 Jul 2021 27,439 73,054 (0%) 0% 121 3,320,119 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2021 25,120 0 - - Stock Option (Right to Buy)
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.60 per share. 01 Jul 2021 25,120 45,615 (0%) 0% 36.6 919,392 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.60 per share. 01 Jul 2021 19,879 55,555 (0%) 0% 36.6 727,571 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2021 19,879 25,120 - - Stock Option (Right to Buy)
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 121.00 per share. 01 Jul 2021 17,560 73,115 (0%) 0% 121 2,124,760 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2021 17,560 27,439 - - Stock Option (Right to Buy)
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.60 per share. 01 Jul 2021 15,181 35,676 (0%) 0% 25.6 388,634 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2021 15,181 0 - - Stock Option (Right to Buy)
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 214.13 per share. 01 Jul 2021 12,917 28,808 (0%) 0% 214.1 2,765,878 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 213.07 per share. 01 Jul 2021 12,703 41,725 (0%) 0% 213.1 2,706,641 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 217.84 per share. 01 Jul 2021 9,969 34,252 (0%) 0% 217.8 2,171,652 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 212.29 per share. 01 Jul 2021 7,616 59,226 (0%) 0% 212.3 1,616,784 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 218.77 per share. 01 Jul 2021 7,423 26,829 (0%) 0% 218.8 1,623,942 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 214.97 per share. 01 Jul 2021 6,984 21,824 (0%) 0% 215.0 1,501,337 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 212.15 per share. 01 Jul 2021 6,419 54,428 (0%) 0% 212.2 1,361,808 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 210.02 per share. 01 Jul 2021 6,105 64,964 (0%) 0% 210.0 1,282,190 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 215.74 per share. 01 Jul 2021 5,190 47,215 (0%) 0% 215.7 1,119,694 Common Stock
Novavax, Inc.
Stanley Charles Erck Director, President and CEO Sale of securities on an exchange or to another person at price $ 219.76 per share. 01 Jul 2021 5,031 21,798 (0%) 0% 219.8 1,105,615 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades